HEADER HYDROLASE 17-DEC-14 4UEF OBSLTE 15-FEB-23 4UEF 6I6Z TITLE CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH THE TITLE 2 PHOSPHINIC INHIBITOR ACETYL-TYR-ALA-Y(PO2CH2)-HOMOPHE-OH COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBOXYPEPTIDASE A1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CARBOXYPEPTIDASE DOMAIN, RESIDUES 111-419; COMPND 5 SYNONYM: HUMAN CARBOXYPEPTIDASE A1; COMPND 6 EC: 3.4.17.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: PANCREATIC; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: KM71H; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PPICZ-ALPHA KEYWDS HYDROLASE, CPA1, PHOSPHINIC INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR P.GALLEGO,G.COVALEDA,L.COSTENARO,L.DEVEL,V.DIVE,F.X.AVILES,D.REVERTER REVDAT 2 15-FEB-23 4UEF 1 OBSLTE REMARK LINK REVDAT 1 20-JAN-16 4UEF 0 JRNL AUTH P.GALLEGO,G.COVALEDA,L.DEVEL,V.DIVE,F.X.AVILES,D.REVERTER JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN JRNL TITL 2 COMPLEX WITH PHOSPHINIC INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 79.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 65603 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.160 REMARK 3 R VALUE (WORKING SET) : 0.158 REMARK 3 FREE R VALUE : 0.187 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3476 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.69 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4477 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.83 REMARK 3 BIN R VALUE (WORKING SET) : 0.2010 REMARK 3 BIN FREE R VALUE SET COUNT : 204 REMARK 3 BIN FREE R VALUE : 0.2270 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4865 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 359 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.17000 REMARK 3 B22 (A**2) : -0.34000 REMARK 3 B33 (A**2) : 0.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.095 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.092 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.053 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.482 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5136 ; 0.028 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7005 ; 2.191 ; 1.938 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 625 ; 6.059 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 229 ;33.093 ;23.930 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 799 ;12.585 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;17.457 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 764 ; 0.203 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3949 ; 0.014 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3085 ; 1.408 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5001 ; 2.290 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2051 ; 3.419 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2004 ; 5.329 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 113 A 418 REMARK 3 ORIGIN FOR THE GROUP (A): -4.5604 1.7858 -16.3333 REMARK 3 T TENSOR REMARK 3 T11: 0.0033 T22: 0.0059 REMARK 3 T33: 0.0134 T12: 0.0015 REMARK 3 T13: 0.0004 T23: -0.0027 REMARK 3 L TENSOR REMARK 3 L11: 0.2133 L22: 0.3418 REMARK 3 L33: 0.4643 L12: -0.0240 REMARK 3 L13: -0.0526 L23: 0.0439 REMARK 3 S TENSOR REMARK 3 S11: -0.0088 S12: 0.0110 S13: -0.0242 REMARK 3 S21: -0.0106 S22: -0.0040 S23: -0.0131 REMARK 3 S31: 0.0100 S32: -0.0369 S33: 0.0128 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 113 B 418 REMARK 3 ORIGIN FOR THE GROUP (A): -12.0429 38.7682 -22.9588 REMARK 3 T TENSOR REMARK 3 T11: 0.0055 T22: 0.0113 REMARK 3 T33: 0.0150 T12: 0.0045 REMARK 3 T13: 0.0065 T23: 0.0121 REMARK 3 L TENSOR REMARK 3 L11: 0.2211 L22: 0.7346 REMARK 3 L33: 0.4410 L12: 0.0539 REMARK 3 L13: -0.1403 L23: -0.1009 REMARK 3 S TENSOR REMARK 3 S11: -0.0032 S12: 0.0305 S13: 0.0165 REMARK 3 S21: -0.0014 S22: 0.0286 S23: 0.0419 REMARK 3 S31: -0.0274 S32: -0.0292 S33: -0.0254 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS.U VALUES WITH TLS ADDED REMARK 4 REMARK 4 4UEF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1290062605. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 69199 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.690 REMARK 200 RESOLUTION RANGE LOW (A) : 46.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 7.10 REMARK 200 R MERGE FOR SHELL (I) : 0.43000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2V77 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.06050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.09750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.05450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.09750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.06050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.05450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 111 REMARK 465 ARG A 112 REMARK 465 TYR A 419 REMARK 465 ALA B 111 REMARK 465 TYR B 419 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TRP A 173 CE3 TRP A 173 CZ3 0.118 REMARK 500 GLN A 198 CG GLN A 198 CD 0.143 REMARK 500 GLU A 283 CG GLU A 283 CD 0.119 REMARK 500 GLU A 283 CD GLU A 283 OE2 0.067 REMARK 500 GLU B 283 CG GLU B 283 CD 0.123 REMARK 500 VAL B 337 CB VAL B 337 CG2 -0.166 REMARK 500 SER B 376 CB SER B 376 OG 0.079 REMARK 500 PHE B 379 CZ PHE B 379 CE2 0.114 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 192 CB - CG - CD2 ANGL. DEV. = -4.5 DEGREES REMARK 500 ASP A 203 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 VAL A 323 CG1 - CB - CG2 ANGL. DEV. = 13.3 DEGREES REMARK 500 ASP A 383 CB - CG - OD2 ANGL. DEV. = -6.6 DEGREES REMARK 500 ARG A 386 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 LEU B 213 CB - CG - CD2 ANGL. DEV. = -10.8 DEGREES REMARK 500 VAL B 323 CG1 - CB - CG2 ANGL. DEV. = 11.7 DEGREES REMARK 500 VAL B 323 CA - CB - CG1 ANGL. DEV. = 9.1 DEGREES REMARK 500 LEU B 343 CB - CG - CD2 ANGL. DEV. = -11.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 232 -46.07 -138.79 REMARK 500 THR A 239 -171.58 -68.90 REMARK 500 ASN A 298 35.56 -140.98 REMARK 500 ASN A 298 35.00 -140.98 REMARK 500 SER A 309 -16.30 152.76 REMARK 500 GLN A 310 67.73 61.11 REMARK 500 ILE A 357 -70.60 -127.65 REMARK 500 ASP A 383 -145.42 -108.01 REMARK 500 LEU A 390 37.19 -92.97 REMARK 500 THR B 232 -46.79 -140.60 REMARK 500 THR B 239 -174.86 -68.29 REMARK 500 SER B 309 -2.39 149.45 REMARK 500 SER B 309 -18.81 157.20 REMARK 500 GLN B 310 64.36 62.56 REMARK 500 GLN B 310 64.36 63.22 REMARK 500 ILE B 357 -66.95 -132.53 REMARK 500 TYR B 358 169.72 179.32 REMARK 500 ASP B 383 -146.91 -109.53 REMARK 500 LEU B 390 37.70 -90.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1420 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 179 ND1 REMARK 620 2 GLU A 182 OE2 99.4 REMARK 620 3 HIS A 306 ND1 103.1 133.0 REMARK 620 4 TJE A1419 O4 126.5 101.7 97.1 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1420 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 179 ND1 REMARK 620 2 GLU B 182 OE2 98.1 REMARK 620 3 HIS B 306 ND1 102.5 134.3 REMARK 620 4 TJE B1419 O4 122.8 102.3 100.0 REMARK 620 N 1 2 3 REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: (2S)-2-{[(S)-{(1R)-1-[(N-ACETYL-L-TYROSYL)AMINO] REMARK 630 ETHYL}(HYDROXY)PHOSPHORYL]METHYL}-4-PHENYLBUTANOIC ACID REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 TJE A 1419 REMARK 630 TJE B 1419 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: ACY TYR WN6 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TJE A 1419 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1420 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TJE B 1419 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1420 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UEE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH REMARK 900 THE PHOSPHINIC INHBITOR ACETYL-LEU-ALA-Y (PO2CH2)-HOMOPHE-OH DBREF 4UEF A 111 419 UNP P15085 CBPA1_HUMAN 111 419 DBREF 4UEF B 111 419 UNP P15085 CBPA1_HUMAN 111 419 SEQRES 1 A 309 ALA ARG SER THR ASP THR PHE ASN TYR ALA THR TYR HIS SEQRES 2 A 309 THR LEU GLU GLU ILE TYR ASP PHE LEU ASP LEU LEU VAL SEQRES 3 A 309 ALA GLU ASN PRO HIS LEU VAL SER LYS ILE GLN ILE GLY SEQRES 4 A 309 ASN THR TYR GLU GLY ARG PRO ILE TYR VAL LEU LYS PHE SEQRES 5 A 309 SER THR GLY GLY SER LYS ARG PRO ALA ILE TRP ILE ASP SEQRES 6 A 309 THR GLY ILE HIS SER ARG GLU TRP VAL THR GLN ALA SER SEQRES 7 A 309 GLY VAL TRP PHE ALA LYS LYS ILE THR GLN ASP TYR GLY SEQRES 8 A 309 GLN ASP ALA ALA PHE THR ALA ILE LEU ASP THR LEU ASP SEQRES 9 A 309 ILE PHE LEU GLU ILE VAL THR ASN PRO ASP GLY PHE ALA SEQRES 10 A 309 PHE THR HIS SER THR ASN ARG MET TRP ARG LYS THR ARG SEQRES 11 A 309 SER HIS THR ALA GLY SER LEU CYS ILE GLY VAL ASP PRO SEQRES 12 A 309 ASN ARG ASN TRP ASP ALA GLY PHE GLY LEU SER GLY ALA SEQRES 13 A 309 SER SER ASN PRO CYS SER GLU THR TYR HIS GLY LYS PHE SEQRES 14 A 309 ALA ASN SER GLU VAL GLU VAL LYS SER ILE VAL ASP PHE SEQRES 15 A 309 VAL LYS ASP HIS GLY ASN ILE LYS ALA PHE ILE SER ILE SEQRES 16 A 309 HIS SER TYR SER GLN LEU LEU MET TYR PRO TYR GLY TYR SEQRES 17 A 309 LYS THR GLU PRO VAL PRO ASP GLN ASP GLU LEU ASP GLN SEQRES 18 A 309 LEU SER LYS ALA ALA VAL THR ALA LEU ALA SER LEU TYR SEQRES 19 A 309 GLY THR LYS PHE ASN TYR GLY SER ILE ILE LYS ALA ILE SEQRES 20 A 309 TYR GLN ALA SER GLY SER THR ILE ASP TRP THR TYR SER SEQRES 21 A 309 GLN GLY ILE LYS TYR SER PHE THR PHE GLU LEU ARG ASP SEQRES 22 A 309 THR GLY ARG TYR GLY PHE LEU LEU PRO ALA SER GLN ILE SEQRES 23 A 309 ILE PRO THR ALA LYS GLU THR TRP LEU ALA LEU LEU THR SEQRES 24 A 309 ILE MET GLU HIS THR LEU ASN HIS PRO TYR SEQRES 1 B 309 ALA ARG SER THR ASP THR PHE ASN TYR ALA THR TYR HIS SEQRES 2 B 309 THR LEU GLU GLU ILE TYR ASP PHE LEU ASP LEU LEU VAL SEQRES 3 B 309 ALA GLU ASN PRO HIS LEU VAL SER LYS ILE GLN ILE GLY SEQRES 4 B 309 ASN THR TYR GLU GLY ARG PRO ILE TYR VAL LEU LYS PHE SEQRES 5 B 309 SER THR GLY GLY SER LYS ARG PRO ALA ILE TRP ILE ASP SEQRES 6 B 309 THR GLY ILE HIS SER ARG GLU TRP VAL THR GLN ALA SER SEQRES 7 B 309 GLY VAL TRP PHE ALA LYS LYS ILE THR GLN ASP TYR GLY SEQRES 8 B 309 GLN ASP ALA ALA PHE THR ALA ILE LEU ASP THR LEU ASP SEQRES 9 B 309 ILE PHE LEU GLU ILE VAL THR ASN PRO ASP GLY PHE ALA SEQRES 10 B 309 PHE THR HIS SER THR ASN ARG MET TRP ARG LYS THR ARG SEQRES 11 B 309 SER HIS THR ALA GLY SER LEU CYS ILE GLY VAL ASP PRO SEQRES 12 B 309 ASN ARG ASN TRP ASP ALA GLY PHE GLY LEU SER GLY ALA SEQRES 13 B 309 SER SER ASN PRO CYS SER GLU THR TYR HIS GLY LYS PHE SEQRES 14 B 309 ALA ASN SER GLU VAL GLU VAL LYS SER ILE VAL ASP PHE SEQRES 15 B 309 VAL LYS ASP HIS GLY ASN ILE LYS ALA PHE ILE SER ILE SEQRES 16 B 309 HIS SER TYR SER GLN LEU LEU MET TYR PRO TYR GLY TYR SEQRES 17 B 309 LYS THR GLU PRO VAL PRO ASP GLN ASP GLU LEU ASP GLN SEQRES 18 B 309 LEU SER LYS ALA ALA VAL THR ALA LEU ALA SER LEU TYR SEQRES 19 B 309 GLY THR LYS PHE ASN TYR GLY SER ILE ILE LYS ALA ILE SEQRES 20 B 309 TYR GLN ALA SER GLY SER THR ILE ASP TRP THR TYR SER SEQRES 21 B 309 GLN GLY ILE LYS TYR SER PHE THR PHE GLU LEU ARG ASP SEQRES 22 B 309 THR GLY ARG TYR GLY PHE LEU LEU PRO ALA SER GLN ILE SEQRES 23 B 309 ILE PRO THR ALA LYS GLU THR TRP LEU ALA LEU LEU THR SEQRES 24 B 309 ILE MET GLU HIS THR LEU ASN HIS PRO TYR HET TJE A1419 34 HET ZN A1420 1 HET TJE B1419 34 HET ZN B1420 1 HETNAM TJE (2S)-2-{[(S)-{(1R)-1-[(N-ACETYL-L-TYROSYL) HETNAM 2 TJE AMINO]ETHYL}(HYDROXY)PHOSPHORYL]METHYL}-4- HETNAM 3 TJE PHENYLBUTANOIC ACID HETNAM ZN ZINC ION HETSYN TJE ACETYL-TYR-ALA-Y(PO2CH2)-HOMOPHE-OH FORMUL 3 TJE 2(C24 H31 N2 O7 P) FORMUL 4 ZN 2(ZN 2+) FORMUL 7 HOH *359(H2 O) HELIX 1 1 THR A 124 ASN A 139 1 16 HELIX 2 2 GLU A 182 TYR A 200 1 19 HELIX 3 3 ASP A 203 ASP A 211 1 9 HELIX 4 4 ASN A 222 THR A 232 1 11 HELIX 5 5 ASP A 252 ASN A 256 5 5 HELIX 6 6 GLU A 283 GLY A 297 1 15 HELIX 7 7 ASP A 325 SER A 342 1 18 HELIX 8 8 ILE A 353 ILE A 357 1 5 HELIX 9 9 SER A 363 GLN A 371 1 9 HELIX 10 10 PRO A 392 SER A 394 5 3 HELIX 11 11 GLN A 395 HIS A 417 1 23 HELIX 12 12 THR B 124 ASN B 139 1 16 HELIX 13 13 GLU B 182 TYR B 200 1 19 HELIX 14 14 ASP B 203 LEU B 213 1 11 HELIX 15 15 ASN B 222 THR B 232 1 11 HELIX 16 16 ASP B 252 ASN B 256 5 5 HELIX 17 17 GLU B 283 GLY B 297 1 15 HELIX 18 18 ASP B 325 SER B 342 1 18 HELIX 19 19 ILE B 353 ILE B 357 1 5 HELIX 20 20 SER B 363 GLN B 371 1 9 HELIX 21 21 PRO B 392 SER B 394 5 3 HELIX 22 22 GLN B 395 HIS B 417 1 23 SHEET 1 AA 8 VAL A 143 ASN A 150 0 SHEET 2 AA 8 PRO A 156 PHE A 162 -1 O ILE A 157 N ILE A 148 SHEET 3 AA 8 ASP A 214 GLU A 218 -1 O ILE A 215 N PHE A 162 SHEET 4 AA 8 ALA A 171 THR A 176 1 O ILE A 172 N PHE A 216 SHEET 5 AA 8 ILE A 299 HIS A 306 1 N LYS A 300 O ALA A 171 SHEET 6 AA 8 TYR A 375 GLU A 380 1 O TYR A 375 N PHE A 302 SHEET 7 AA 8 LEU A 311 TYR A 314 -1 O LEU A 311 N GLU A 380 SHEET 8 AA 8 ASN A 349 SER A 352 1 O ASN A 349 N LEU A 312 SHEET 1 BA 8 VAL B 143 ASN B 150 0 SHEET 2 BA 8 PRO B 156 PHE B 162 -1 O ILE B 157 N ILE B 148 SHEET 3 BA 8 ASP B 214 GLU B 218 -1 O ILE B 215 N PHE B 162 SHEET 4 BA 8 ALA B 171 THR B 176 1 O ILE B 172 N PHE B 216 SHEET 5 BA 8 ILE B 299 HIS B 306 1 N LYS B 300 O ALA B 171 SHEET 6 BA 8 TYR B 375 GLU B 380 1 O TYR B 375 N PHE B 302 SHEET 7 BA 8 LEU B 311 TYR B 314 -1 O LEU B 311 N GLU B 380 SHEET 8 BA 8 ASN B 349 SER B 352 1 O ASN B 349 N LEU B 312 SSBOND 1 CYS A 248 CYS A 271 1555 1555 2.17 SSBOND 2 CYS B 248 CYS B 271 1555 1555 2.15 LINK ND1 HIS A 179 ZN ZN A1420 1555 1555 2.06 LINK OE2 GLU A 182 ZN ZN A1420 1555 1555 1.97 LINK ND1 HIS A 306 ZN ZN A1420 1555 1555 1.99 LINK O4 TJE A1419 ZN ZN A1420 1555 1555 2.06 LINK ND1 HIS B 179 ZN ZN B1420 1555 1555 2.08 LINK OE2 GLU B 182 ZN ZN B1420 1555 1555 2.01 LINK ND1 HIS B 306 ZN ZN B1420 1555 1555 1.99 LINK O4 TJE B1419 ZN ZN B1420 1555 1555 2.07 CISPEP 1 SER A 307 TYR A 308 0 -5.53 CISPEP 2 PRO A 315 TYR A 316 0 -0.43 CISPEP 3 ARG A 382 ASP A 383 0 -7.12 CISPEP 4 SER B 307 TYR B 308 0 -2.58 CISPEP 5 PRO B 315 TYR B 316 0 -2.90 CISPEP 6 ARG B 382 ASP B 383 0 -2.95 SITE 1 AC1 20 HIS A 179 ARG A 181 GLU A 182 ARG A 237 SITE 2 AC1 20 ASN A 254 ARG A 255 GLU A 273 HIS A 306 SITE 3 AC1 20 SER A 307 TYR A 308 ILE A 353 TYR A 358 SITE 4 AC1 20 SER A 363 THR A 378 GLU A 380 PHE A 389 SITE 5 AC1 20 ZN A1420 HOH A2056 GLU B 273 TJE B1419 SITE 1 AC2 4 HIS A 179 GLU A 182 HIS A 306 TJE A1419 SITE 1 AC3 20 GLU A 273 TJE A1419 HIS B 179 ARG B 181 SITE 2 AC3 20 GLU B 182 ARG B 237 ASN B 254 ARG B 255 SITE 3 AC3 20 HIS B 306 SER B 307 TYR B 308 ILE B 353 SITE 4 AC3 20 TYR B 358 SER B 363 THR B 378 GLU B 380 SITE 5 AC3 20 PHE B 389 ZN B1420 HOH B2055 HOH B2139 SITE 1 AC4 4 HIS B 179 GLU B 182 HIS B 306 TJE B1419 CRYST1 46.121 84.109 158.195 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021682 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011889 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006321 0.00000